Navigation Links
Alzheimer's & Dementia: The Journal of the Alzheimer's Association accepted for coverage in MEDLINE
Date:7/24/2008

Philadelphia, July 24, 2008 Elsevier and the Alzheimer's Association announced that Alzheimer's & Dementia: The Journal of the Alzheimer's Association (www.alzheimersanddementia.org) has been selected for inclusion in MEDLINE. MEDLINE (www.pubmed.gov) is the premier bibliographic database of the National Library of Medicine (NLM). Part of the National Institutes of Health (NIH), MEDLINE contains over 16 million journal article citations, with a concentration on biomedicine.

"The entire Editorial Board and I are extremely pleased that Alzheimer's & Dementia is being added to the MEDLINE journal collection so soon after its launch in 2005," Alzheimer's & Dementia Editor Zaven Khachaturian, PhD, commented. "Inclusion in this prominent database signals recognition of the journal's scientific merit and contribution to the field of Alzheimer's research. More importantly, MEDLINE indexing will help researchers and other interested parties worldwide to locate articles published in Alzheimer's & Dementia."

As the official journal of the Alzheimer's Association, the peer-reviewed Alzheimer's & Dementia is distributed bimonthly to members of the Association's International Society to Advance Alzheimer Research and Treatment (ISTAART), as well as other subscribers and libraries. Alzheimer's & Dementia addresses challenging issues facing researchers, clinicians and health policymakers on topics from healthy brain aging to all forms of dementia. Unlike other journals in the field, Alzheimer's & Dementia brings together breakthrough research and new thinking across diverse areas of investigation. This interdisciplinary journal provides the impetus for new scientific initiatives and offers probing, thought-provoking studies, articles and reviews from the leading minds in the field.

"With Alzheimer's research increasingly garnering international attention and interest, it is critical for clinicians and investigators in this interdisciplinary field to have the most cutting edge, authoritative information available," said William Thies, PhD, Vice President for Medical & Scientific Relations at the Alzheimer's Association. "Progress is being made, and we are beginning to reap the benefits of scientific advancements made in the last two decades. But we must move the field forward more quickly for the benefit of the millions now with Alzheimer's, their caregivers and family members. Alzheimer's & Dementia can play an important role in doing that."

As publishing partners, the Alzheimer's Association and Elsevier are delighted that researchers and practitioners worldwide can now easily find the valuable information offered in Alzheimer's & Dementia through MEDLINE.


'/>"/>

Contact: Caroline Foote
c.foote@elsevier.com
215-239-3653
Elsevier
Source:Eurekalert

Related medicine news :

1. Alzheimers Research Target May Be a Dead End
2. Vertos Medical Inc. Presents Clinical Data of its MILD™ Procedure at the 5th Annual Innovative Techniques in Spine Surgery Conference in Los Cabos, Mexico
3. VendorClear™ Introduces Revolutionary Products for Healthcare Facilities and Vendor Representatives
4. National Non-Profit, EyeCare America, and the Maryland Society of Eye Physicians & Surgeons Host Finish Line Celebration for “EyeRide for Sight” Cyclists
5. John A. Millard, M.D. is 1st Surgeon in Colorado to Offer Smartlipo MPX™
6. New MagnaBloc™ Product Available from Gradient Medical
7. Texas Oncology Urges Texans to ‘Save Your Skin:' Outsmart the Sun and Prevent Skin Cancer
8. The Mesothelioma Victims Center Offers Victims Of Asbestos Related Cancer & Their Loved Ones The Most Comprehensive Free Service Especially For US Navy Veterans
9. Birchwood Laboratories Expands B-SURE™ Incontinence and Personal Care Product Line™; Three New Products Added Including B-SURE Fresh 'n Go™, B-SURE Bottom Balm™ and B-SURE Traveler™
10. Contract Research Development Debuts at MD&M Touting Expertise, Innovation and Collaboration
11. Special supplement on self-monitoring of blood glucose in diabetes technology & therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... New York, NY (PRWEB) , ... April 28, ... ... Shiel Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast ... indicates recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically ...
(Date:4/28/2017)... California (PRWEB) , ... April 28, 2017 , ... ... T8 Direct Replace tubes . These lamps offer an instant energy-saving solution for ... need to rewire fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize ...
(Date:4/28/2017)... Manhattan New york (PRWEB) , ... April 28, ... ... is pleased to announce that Aditya Patel M.D. has joined the revolutionary endoscopic ... fellowship training and board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt ...
(Date:4/28/2017)... ... ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical organization GenCure, ... at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord blood donations ... , “Women’s Hospital at Renaissance has been a collection partner for the TCBB since ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... could substantially improve drug safety and minimize the cost of development. In this ... channel inhibition using cell lines and for cardiac toxicity using induced pluripotent stem ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)... 19, 2017 Companion ... response in pets such as canine, avian and ... various types such as Attenuated Live Vaccines, Conjugate ... Vaccines and Recombinant Vaccines. Attenuated live vaccines are ... bacteria, which have been weakend under laboratory conditions. ...
(Date:4/18/2017)... DUBLIN, Ohio , April 18, 2017  Cardinal ... its Non-GAAP 1 fiscal 2017 earnings per share ... 2018 and 2019.  This is in conjunction with this ... Care, Deep Vein Thrombosis and Nutritional Insufficiency businesses. ... EPS from continuing operations will be at the bottom ...
Breaking Medicine Technology: